Advantex Bioreagents LLC
Records under this name other than patents Advantex Bioreagents LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to Advantex Bioreagents LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,642,050 | Method for predicting responsiveness of breast cancer to antiestrogen therapy Term ended Term ended Oct 4, 2021 · From the USPTO record | Term ended | Term ended Oct 4, 2021 | From the USPTO record |
| US 7,306,921 | Diagnostic and monitoring methods for cancer Lapsed on the fee record Ended Dec 11, 2019 · From the USPTO record | Lapsed on the fee record | Ended Dec 11, 2019 | From the USPTO record |